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Participants from vulnerable populations in most modern clinical trials are 
underrepresented thereby impacting the generalizability of clinical trial results.  This is 
particularly worrisome – where the intervention is behavioral and the outcome is cancer 
screening– as both are not well understood but are essential to addressing cancer health 
disparities and closing gaps in care. We used the World Health Organization’s (WHO) social 
determinants of health to frame results of clinical trial participation, long-term follow-up, and 
cervical cancer prevention outcomes among vulnerable participants- women leaving 
incarceration. 
Methods: 
 Three years of follow-up data from a cervical cancer behavioral intervention clinical trial 
that took place in three county jails between 2014 and 2016 was used to report three outcomes: 
a) clinical trial completion for women in jails; b) factors associated with best practice community 
follow-up of women three years after the jail-based intervention; c) cervical cancer health 
literacy and up-to-date Pap testing at three-year follow-up. 
Results: 
Of the 261 women who consented to be in the original jail-based clinical trial (about half 
of the women incarcerated at local jails were recruited on any given day), 114/142 (80.3%) of 
those assigned to the intervention group completed the intervention. 70/119 (58.8%) of those in 
the waitlist control group completed the intervention. The primary factor associated with 
completion of the jail-based intervention was being assigned to the intervention group in Week 1 
(by Week 2 when the control group received the intervention, 32 had been discharged from jails 
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or transferred, 5 were cancelled by the intervention study staff, and 12 for other reasons). One 
hundred eleven of the 182 (61%) of intervention completers were retained at three years post-
intervention and completed all pre, post, and year 3 assessments. Predictors of long-term follow-
up included food security and lower utilization of public benefits. Among these participants, with 
regards to the cervical health literacy, there were statistically significant gains in three of the 
eight cervical health literacy domains when compared to post-intervention scores and seven of 
the eight domains when compared to pre-intervention scores (p < 0.05). Statistically significant 
predictors of cervical health literacy scores at year three included age within the confidence 
domain (b = 0.03, p = 0.030), education level within the susceptibility domain (b = – 0.82, p = 
0.006), food insecurity within the barrier domain (b = 0.70, p = 0.006), having a past cervical 
cancer diagnosis within the severity domain (b = –1.15, p = 0.012), having received public 
benefits within the motivation domain (b = 0.62, p =  0.038) and having experienced racism 
within the self-efficacy domain ( b = – 0.90, p = 0.033). Despite these improvements to cervical 
health literacy, up-to-date Pap testing remained steady at 74% compared to 75% at baseline (p = 
0.679).   
Conclusion: 
These findings illuminate how WHO social determinants of health predict clinical trial 
participation, long-term follow-up, and outcomes among vulnerable women. The study offers 
insights into how clinical trials for behavioral approaches to cancer prevention can be designed, 
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Clinical trials are recognized by the medical community as a gold standard guiding 
evidence based medical practice and public health policy decisions.  Women are one of the 
fastest growing segments of the incarcerated population, yet incarcerated women are largely 
underrepresented in modern clinical trials. The consequences of underrepresentation in clinical 
trials raises concerns over the applicability of results for this vulnerable population and in turn 
contributes to widening health disparities.  The social determinants of health, defined by the 
World Health Organization (WHO) as “the conditions in which people are born, grow, live, 
work, and age”, are a well-established significant contributor to health inequity.  However, the 
influences exerted by social determinants have not been explored in the context of participation, 
long-term follow-up, and outcomes in a clinical trial involving incarcerated women. For the 
benefit of public health, it is imperative to improve access, retention, and outcomes in clinical 
trials involving incarcerated women. Accomplishing this will require novel approaches that seek 






































The Incarcerated Population 
Randomized clinical trials serve as a gold standard for determining the efficacy of an 
intervention, ultimately guiding clinical practice and policy making. It is well established that 
incarcerated populations are underrepresented in modern clinical trials, raising concerns for the 
validity of results within these groups (1,2).  With more than 9% of the U.S. population having 
ever been incarcerated and these populations being disproportionately poor and Black or Latinx, 
this sizable and vulnerable segment of the population confronts poorer health outcomes that 
clinical trials have largely failed to address (3,4).  Incarcerated women, who face additional 
social stigmatization surrounding gender, represent one of the fastest growing incarcerated 
demographics having seen a 750% increase in incarceration rates between 1980-2017 (5).  The 
health disparities experienced by incarcerated women are exemplified when considering that a 
largely preventable condition, cervical cancer, is 4-5 times more prevalent compared to age 
matched samples of noninstitutionalized women (4).  In order to improve health equity, it is 
critical to examine the forces that limit engagement of this population in clinical trials and how 
to design those trials to best engage and follow vulnerable women.  
Social Determinants of Health Model 
 In 2010, the World Health Organization’s (WHO) Commission on Social Determinants 
of Health established a theoretical framework to better understand the effects of social 
determinants on population health. This framework divides social determinants into two broader 
categories: structural determinants and intermediary determinants. Structural determinants 
include the social, economic, and political mechanisms that create socioeconomic positions and 
stratify populations via income, education, occupation, gender, and ethnoracial status. 
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Consequently, socioeconomic position establishes the intermediary determinants of health which 
are characterized by differences in exposure and vulnerability specific to that socioeconomic 
position. Intermediary determinants consist of material circumstances, psychosocial 
circumstances, behavioral and biological factors, and health system factors. These intermediary 
determinants then have a direct impact on health status.  Importantly, health status can also 
feedback and influence socioeconomic position by say reducing opportunity for employment due 
to illness (6). The effects of social determinants on health are observed in United States life 
expectancy data where higher educational attainment or being White are both associated with 
longer life expectancy (7). A less abstract example are findings where children who pertained to 
lower socioeconomic status were found to have less access to recreational facilities and 
nutritious foods leading to higher rates of being overweight or obese (7). The effects of social 
determinants have also been applied within the context of a clinical trial. When data from the 
Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) was 
stratified into income quintiles, it was found that the lowest income quintile was less likely to 
achieve blood pressure control and had greater all-cause mortality (8).  Having explained the 
social determinants framework employed in this paper, it is necessary to describe the various 
levels of barriers that reduce participation in clinical trials for incarcerated women.  
Systemic Barriers 
 There are many barriers limiting participation in clinical trials for incarcerated women. 
From a systemic standpoint, adoption of subpart C of the protection of human research subjects 
arose from a need to discontinue unethical research practices that historically exploited prisoners. 
However, if the proposed research does not fit into one of the four approved categories then 
‘biomedical or behavioral research shall not involve prisoners as subjects’. Further, there are no 
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uniform guidelines for inmates’ access to clinical research between private, local, state, and 
federal prisons. Thus, research at a specific facility must comply with administrative policies set 
forth by the individual site (9).  These additional regulations, although they have reversed 
practices that historically exploitated incarcerated populations, have had the unintended 
consequence of serving as a justification for funding agencies and biomedical researchers to 
neglect this population (9).  The limited engagement of this population by the research 
community is made apparent in considering that between 2008 to 2012 only 180 or less than 
0.1% of NIH awarded grants were allocated for criminal justice health research (10). Specific to 
clinical trials, Kouyoumdjian et al. conducted a systematic review of published clinical trials in 
14 databases without a time interval applied. Of the 3113 identified clinical trials, 95 involved 
incarcerated populations and of these only 13 were specific to incarcerated women (11). Aside 
from these systemic constraints, incarcerated populations also face barriers to enrollment at the 
level of healthcare providers.  
 Healthcare Provider Barriers 
Clinical trial access hinges largely on healthcare providers offering participation and 
biases at this level add barriers for incarcerated populations. A study at a large NCI affiliated 
academic center found that women who were offered participation in breast cancer clinical trials 
were twice as likely to be White than Black. The primary reason cited for not offering clinical 
trials to Black women was that they were thought to have “poor performance status and 
inadequate organ function” and 100% of those who were not offered participation due to 
“noncompliance” were Black (12). Additionally, a survey of 130 oncologists throughout 
Pennsylvania found that their perception of patient “mistrust in the medical system” and “a lack 
of understanding” were the main barriers to enrolling patients in clinical trials (13).  In turn, 
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biases from healthcare providers propagate the lack of representation of incarcerated women in 
clinical trials. Aside from these more upstream barriers, there are downstream barriers that are 
also necessary to consider.    
Individual Barriers 
Finally, at the level of the individual there are many barriers that can preclude 
participation and retention of incarcerated people in clinical trials. Estimates have found that up 
to 90% of those released from jails lack health insurance or the ability to pay for medical costs 
(14,15).  Although the affordable care act mandated insurer financial coverage of federally 
sponsored clinical trials, the mandate did not extend to those insured through Medicaid or the 
uninsured (16). For these populations, the need to secure alternative funding mechanisms is a 
deterrent reducing rates of participation (14). However, even if the insurer covers the trial, 
financial costs associated with participation remain. A report out of Massachusetts General 
Hospital, found that on average those who participated in clinical trials spent more than $600 per 
month in additional costs such as travel and lodging (17). This added cost over the long term can 
be further prohibitive for women with criminal justice histories.  
Despite there being a clear need for greater representation of incarcerated women in 
clinical trials, the literature is sparse on proposed mechanisms that affect this at the level of a 
single trial.  This study seeks explore this topic further by considering the World Health 
Organization’s social determinants of health framework and its influence on participation, 

















Participants were recruited on a rolling basis from three county jails on both sides of the 
state border in Kansas City. Convenience sampling was used by posting recruitment flyers in 
common areas, word-of-mouth by jail staff, and direct conversations between participants and 
study staff. Inclusion criteria constituted all English-speaking women age 18 years or older in 
minimum or medium security housing.  As a low risk behavioral intervention, exclusion criteria 
were limited, with only one interested person being excluded on the grounds that their 
psychological distress impeded their ability to provide informed consent. Ultimately, 182 women 
completed the intervention and 78 women did not. Of the 182 women who completed the 
intervention, 111 women completed all pre-intervention, post-intervention, and yearly follow-up 
surveys (18).  
Study Design 
This prospective behavioral clinical trial was conducted as a waitlist control design to 
mitigate ethical concerns of having an untreated control group in this vulnerable population with 
a low-risk behavioral cancer prevention intervention. Once consented, participants completed our 
158-item baseline survey consisting of sociodemographic information, health system navigation, 
and histories of mental health, criminal justice involvement, and sexual and reproductive health.  
Additionally, baseline and all subsequent surveys incorporated questions derived from the Pap 
Knowledge  Scale (19), the Health Belief Model Scale for Cervical Cancer and Pap Smear Test 
(20), the Self-Efficacy Scale for Pap Smear Screening Participation Randomization (21), and 
three questions the team developed based on previous work (22). These questions allowed us to 
operationalize cervical health literacy into the following domains: knowledge, self-efficacy, 
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confidence, and beliefs. Beliefs were then further categorized into benefits, barriers, severity, 
susceptibility, and motivation (20). Trial randomization was achieved based on seating during 
consent, with every other person being assigned to the intervention arm or the waitlist control 
arm. Those assigned to the intervention arm began the intervention program the same day (day 1) 
and following the last session on day 5, completed an 82-item post-intervention survey. The 
waitlist control group began their intervention the following week but, prior to commencing the 
program on day 1, were asked to complete a 73-item pre-intervention survey.  The intervention 
was initially evaluated by observing changes in cervical health literacy between the intervention 
arm’s baseline and post-intervention surveys compared with the control arm’s baseline and pre-
intervention surveys. Since all participants had received the intervention by yearly follow-up, a 
pre-post design was used to evaluate cervical health literacy outcomes as well as changes in up-
to-date Pap testing. A 146-item yearly follow-up survey was administered at years 1, 2, and 3 to 
evaluate cervical health literacy using the aforementioned tools. Additional questions on up-to-
date Pap screening along with relevant changes to sociodemographic information, health system 
navigation, criminal justice involvement, and mental, reproductive, and sexual health histories 
were also included in the follow-up survey (18). 
Intervention 
The Sexual Health Empowerment (SHE) intervention was designed to increase cervical 
health literacy and utilization of cervical cancer screening for incarcerated women. In a small 
group setting of 2 to 10 participants, the intervention was organized into 2-hour daily sessions 
over the course of 5 days. Sessions were facilitated by a sexual health educator and assistant but 
emphasized participants’ collective knowledge and experiences as a means of group 
empowerment (18).  
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Measures 
Survey data collected at baseline and through 3 years of follow-up was used to report on 
the three dependent variables for this study. These included clinical trial completion, retention at 
year three, and cervical cancer prevention outcomes including both sustained cervical health 
literacy and up-to-date Pap screening. We used the World Health Organization’s social 
determinants of health framework to establish independent variables and quantify their effects on 
our dependent variables.  Under this framework we were able to examine both structural 
determinants and intermediary determinants. Structural determinants constituted age, ethnoracial 
status, education, and occupation. Intermediary determinants are further subcategorized into 
material circumstances, behavioral and biological factors, psychosocial factors, and health 
system factors. Material circumstances comprised of housing, consumption potential, food 
security, history of exchanging sex, and transportation. Behavioral and biological factors were 
alcohol and substance use, history of mental illness, history of sexually transmitted infection, 
history of abnormal pap test, and history of cervical cancer. Psychosocial factors included 
lifetime months incarcerated, recipient of public benefits, experiences of discrimination, and 
history of child physical and sexual abuse. Finally, health system factors were insurance status, 
access to a primary care doctor, and having a medical home. 
Statistical Analysis 
Descriptive statistics were utilized to summarize the structural and intermediary 
determinants of health, separately for participants who completed the intervention (n = 182) and 
who did not (n = 79); for participants who completed the intervention and were retained at year 3 
(n = 111) and who completed the intervention but were lost to follow-up (n = 71). Bivariate tests 
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(independent-samples t-test, chi-square or Fisher’s exact test as appropriate) were conducted to 
compare each variable between these participant subgroups.  The participants’ health literacy 
(knowledge, benefits, barriers, severity, susceptibility, motivation, self-efficacy, confidence) and 
Pap screening were summarized at three time points—pre-intervention, post-intervention, and 36 
months after release from jail. Paired-samples t-test was performed to examine the change in 
each variable over the 3-year period Further, general linear modeling was used to examine the 
effects of the structural and intermediary determinants (predictors) on health literacy (outcome) 
after release from jail. Specifically, an ordinary least squares regression model was fitted for 
each of the eight health literacy scores. In line with an intent-to-treat approach, when there were 
missing observations due to either attrition or non-response, all available data from partial 


















































Reprinted here with permission. Ramaswamy, M., Lee, J., Wickliffe, J., Allison, M., Emerson, A., & 
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jailed women. Preventive medicine reports, 6, 314–321. https://doi-
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283 interested 
142 assigned to intervention 
group (54.4 %) 
70 completed the 
intervention (58.8%) 
261 consented (92.2%) 
114 completed the 
intervention (80.3%) 
119 assigned to waitlist 
control group (45.6%) 
22 did not consent 
• 13 declined 
• 9 other 
 49 lost to attrition during 
intervention 
• 32 released from jail 
or transferred 
• 5 due to cancellation 
by study staff 
• 12 other 
 28 lost to attrition during 
intervention 
• 12 released from jail 
or transferred 
• 5 due to cancellation 
by study staff 
• 11 other 
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Baseline 
Of the 261 women consented for the study, 182 completed the intervention and 79 did 
not.  The participant flow chart above does not fully reflect these values as errors were identified 
following publication.  These included four duplicate participants, one woman who completed 
the intervention under the wrong group assignment, and one woman who completed the posttest 
at four weeks as opposed to one week later (23).  Strikingly, 44 participants (16.8%) did not 
complete the intervention as a result of being released from jail or transferred to another facility. 
This is especially apparent in the wait-list control group where 32 participants or nearly 27% did 
not complete the intervention for this reason. These findings reflect the principle explanation 
behind those who completed the intervention and those that did not. It is also worth noting the 
relatively high percentage of completion (80.3%) observed in the immediate intervention group. 
Such findings allude to a strong interest in completing the behavioral clinical trial intervention by 
our sample.  
In considering the structural determinants of health, there were no statistically significant 
differences observed between the intervention completion and intervention non-completion 
groups. The mean age for both groups was around 33 years and both groups had similar 
ethnoracial compositions with around half identifying as an ethnoracial minority and the other 
half identifying as white.  
Similarly, the intermediary determinants within the domains of behavioral and biological 
factors, psychosocial factors, and health system factors yielded no statistically significant 
differences between the intervention completion and intervention non-completion groups. Within 
behavioral and biological factors, both groups had means exceeding 60% for history of substance 
dependence and history of sexually transmitted infection (STI) and greater than 70% for history 
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of mental illness.  Considering psychosocial factors, while mean lifetime months incarcerated 
appear different between the groups (25.55 months for the intervention completers and 21.13 
months for non-completers), there is a tremendous amount of variance with standard of deviation 
nearly doubling the means ( ± 47.77 for intervention completers and ± 39.45 for non-
completers). Under health system factors, more than half of the women in both groups reported 
having no health insurance and less than half of the women in both groups reported having a 
primary care doctor.   
While no statistically significant differences were observed between the two groups in the 
aforementioned domains, there were differences within the domain of material circumstances. Of 
women who completed the intervention, 52.6% reported not having enough money to take care 
of basic monthly needs. In comparison, 67.5% of women who did not complete the intervention 
reported not having enough money to take care of basic monthly needs. This constituted a 
statistically significant difference at a threshold of 0.05 with a calculated p-value of 0.028. Other 
interesting trends within this domain was greater reporting of food insecurity, history of 
exchanging sex, and not having a reliable source of transportation among the intervention non 
completion group. 
Table 1. WHO based determinants of health for those who completed the clinical trial 










Structural Determinants     
Age 33.70 ± 9.95 33.83 ± 9.50 33.39 ± 10.97 0.756 
Ethnoracial status    0.733 
    White 128 (51.0 %) 92 (51.7 %) 36 (49.3 %)  
    Ethnoracial minority 123 (49.0 %) 86 (48.3 %) 37 (50.7 %)  
Education    0.987 
    Less than high school  88 (35.1 %)  62 (35.0 %) 26 (35.1 %)  
    High school or beyond  163 (64.9 %) 115 (65.0 %) 48 (64.9 %)  
Employment status     0.681 
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    Employed 85 (35.3 %) 61 (36.1 %) 24 (33.3 %)   
    Unemployed 156 (64.7 %) 108 (63.9 %) 48 (66.7 %)   
     










Material Circumstances     
    Housing stability 179 (73.1 %) 126 (73.7 %) 53 (71.6 %)   
    Housing instability 66 (26.9 %) 45 (26.3 %) 21 (28.4 %)   
Neighborhood    0.477 
    Fear of violence 101 (40.1 %) 68 (38.6 %) 33 (43.4 %)   
    No fear of violence 151 (59.9 %) 108 (61.4 %) 43 (56.6 %)   
Consumption potential    0.028 
    Basic needs financial stability 107 (42.8 %) 82 (47.4 %) 25 (32.5 %)   
    Basic needs financial instability 143 (57.2 %) 91 (52.6 %) 52 (67.5 %)   
Food insecurity 70 (27.8 %) 46 (26.3 %) 24 (31.2 %) 0.425 
No reliable source of transportation 82 (32.2 %) 52 (29.2 %) 30 (39.0 %) 0.126 
History of exchanging sex 91 (36.8 %) 60 (34.7 %) 31 (41.9 %) 0.282 
     
Behavioral and Biological Factors      
History of harmful alcohol use 132 (50.6 %) 94 (51.7 %) 38 (48.1 %) 0.599 
History of substance dependence 163 (62.5 %) 112 (61.5 %) 51 (64.6 %) 0.644 
History of mental illnessb 191 (73.2 %) 133 (73.1 %) 58 (73.4 %) 0.955 
History of STIsc 163 (62.5 %) 115 (63.2 %) 48 (60.8 %) 0.710 
History of abnormal Pap test 126 (51.4 %) 95 (54.9 %) 31 (43.1 %) 0.091 
Cervical cancer diagnosis 30 (12.0 %) 24 (13.9 %) 6 (7.8 %) 0.172 
     
Psychosocial Factors      
Lifetime months incarcerated 24.20 ± 45.36 25.55 ± 47.77 21.13 ± 39.45 0.441 
Received public benefits 133 (63.3 %) 87 (62.6 %) 46 (64.8 %) 0.754 
Experienced racism 101 (42.3 %) 70 (41.9 %) 31 (43.1 %) 0.870 
Child physical or sexual abuse 74 (56.5 %) 50 (57.5 %) 24 (54.6 %) 0.750 
     
Health System factors      
Pap screening in past three years 174 (74.7 %) 124 (74.7 %) 50 (74.6 %) 0.991 
Has primary care doctor 103 (40.7 %) 69 (39.0 %) 34 (44.7 %) 0.393 
Has medical home 183 (72.3 %) 125 (71.0 %) 58 (75.3 %) 0.482 
No insurance coverage 133 (55.7 %) 96 (57.5 %) 37 (51.4 %) 0.384 
Notes.   
M ± SD; n (%) 
a p values less than 0.05 are in boldface.   
b Lifetime diagnosis of depression, anxiety, bipolar disorder, or post-traumatic stress disorder by 
a clinician. 
c Lifetime diagnosis of hepatitis B or C, human immunodeficiency virus, syphilis, gonorrhea, 
chlamydia, trichomoniasis, herpes, or HPV by a clinician. 
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Three-year follow-up 
 Out of the 182 women who completed the intervention, 111 completed every survey 
through follow-up at year three. Structural determinants including age, education, and 
employment status were fairly similar to the baseline characteristics reported above and there 
were no statistically significant differences in these between the retained group and the group 
lost to follow-up. Surprisingly, an observable trend is the greater proportion of White 
participants (59.7%) being in the lost to follow-up group coupled with a lower proportion of 
Ethnoracial minorities (40.3%) being lost to follow-up. Although this did not constitute a 
statistically significant difference with a p-value of 0.096, this finding was unexpected for this 
study. 
 Within the intermediary determinants, the domains of behavioral and biological factors 
and health system factors yielded no statistically significant differences between the retention 
and loss to follow-up groups.  Group averages for history of substance abuse, history of STI, and 
history of mental illness remained stable as did reporting having a primary care doctor and not 
having insurance. However, in analyzing the domains of psychosocial factors and material 
circumstances, there were some statistically significant differences between the retention and 
loss to follow-up groups. Of the psychosocial factors, it was striking to find that 100% of 
available data reported in the loss to follow-up group received public benefits compared to the 
51.4% reported in the retention group (p-value < 0.001). Interestingly, there was also a 
statistically significant difference in the reported rates of child physical or sexually abuse with 
66.7% in the retained group and 44.4% in the loss to follow-up group reporting such a history (p 
= 0.039). In considering material circumstances, food insecurity was a statistically significant 
difference with 19.6% reporting food insecurity in the retention group compared to 36.8% 
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reporting in the loss to follow-up group (p = 0.012). Although basic monthly need financial 
instability was a statistically significant difference in the baseline analysis, such a difference did 
not carryover between the retention and loss to follow-up groups.  
Table 2. WHO based determinants of health for those who were retained at year 3 versus those 
who were lost to follow-up 
 Total  
(n=182) 
Retained at  
year 3 (n=111) 
Lost to follow-
up (n=71) pa 
Structural Determinants     
Age 33.84 ± 9.48 34.07 ± 10.04 33.47 ± 8.57 0.673 
Ethnoracial status    0.096 
    White 92 (51.7 %) 52 (46.9 %) 40 (59.7 %)  
    Ethnoracial minority 86 (48.3 %) 59 (53.2 %) 27 (40.3 %)  
Education    0.953 
    Less than high school  62 (35.0 %) 38 (34.9 %) 24 (35.3 %)  
    High school or beyond  115 (65.0 %) 71 (65.1 %) 44 (64.7 %)  
Employment status     0.767 
    Employed 61 (36.1 %) 37 (35.2 %) 24 (37.5 %)  
    Unemployed 108 (63.9 %) 68 (64.8 %) 40 (62.5 %)  
     
Intermediary Determinants     
     
Material Circumstances     
Housing    0.561 
    Housing stability 126 (73.7 %) 79 (75.2 %) 47 (71.2 %)  
    Housing instability 45 (26.3 %) 26 (24.8 %) 19 (28.8 %)  
Neighborhood     0.150 
    Fear of violence 68 (38.6 %) 38 (34.6 %) 30 (45.5 %)  
    No fear of violence 108 (61.4 %) 72 (65.5 %) 36 (54.6 %)  
Consumption potential    0.708 
    Basic needs financial stability 82 (47.4 %) 50 (46.3 %) 32 (49.2 %)  
    Basic needs financial instability 91 (52.6 %) 58 (53.7 %) 33 (50.8 %)  
Food insecurity 46 (26.3 %) 21 (19.6 %) 25 (36.8 %) 0.012 
No reliable source of transportation 52 (29.2 %) 29 (26.4 %) 23 (33.8 %) 0.288 
History of exchanging sex 60 (34.7 %) 39 (36.5 %) 21 (31.8 %) 0.534 
     
Behavioral and Biological Factors     
History of harmful alcohol use 94 (51.7 %) 56 (50.5 %) 38 (53.5 %) 0.686 
History of substance dependence 112 (61.5 %) 72 (64.9 %) 40 (56.3 %) 0.249 
History of mental illnessa 133 (73.1 %) 82 (73.9 %) 51 (71.8 %) 0.762 
History of STIsb 115 (63.2 %) 72 (64.9 %) 43 (60.6 %) 0.557 
History of abnormal Pap test 95 (54.9 %) 57 (55.9 %) 38 (53.5 %) 0.759 
Cervical cancer diagnosis 24 (13.9 %) 14 (13.2 %) 10 (14.9 %) 0.750 
     
 20 
 
 Total  
(n=182) 
Retained at  
year 3 (n=111) 
Lost to follow-
up (n=71) pa 
 
Psychosocial Factors     
Lifetime months incarcerated 25.55 ± 47.77 23.51 ± 39.02 28.75 ± 59.12 0.517 
Received public benefits 87 (62.6 %) 55 (51.4 %) 32 (100.0 %) <0.001 
Experienced racism 70 (41.9 %) 45 (43.7 %) 25 (39.1 %) 0.556 
Child physical or sexual abuse 50 (57.5 %) 34 (66.7 %) 16 (44.4 %) 0.039 
     
Health System factors     
Pap screening in past three years 124 (74.7 %) 78 (74.3 %) 46 (75.4 %) 0.872 
Has primary care doctor 69 (39.0 %) 44 (41.1 %) 25 (35.7 %) 0.471 
Has medical home 125 (71.0 %) 80 (73.4 %) 45 (67.2 %) 0.376 
No insurance coverage 96 (57.5 %) 55 (53.9 %) 41 (63.1 %) 0.243 
Notes.   
M ± SD; n (%) 
a p values less than 0.05 are in boldface.   
b Lifetime diagnosis of depression, anxiety, bipolar disorder, or post-traumatic stress disorder by 
a clinician. 
c Lifetime diagnosis of hepatitis B or C, human immunodeficiency virus, syphilis, gonorrhea, 




 When examining the primary intent of the intervention, increasing cervical health 
knowledge and up-to-date Pap testing, there were some paradoxical and unforeseen findings. As 
depicted in figure 2, one of the key findings is the long-term sustained cervical health knowledge 
following the brief intervention. At year three, every domain with the exception of benefit 
demonstrated statistically significant improvement from pre-intervention scores (p < 0.05).  Such 
findings are consistent with the original study, where again benefit was one of two domains to 
not show a statistically significant improvement, demonstrating the prolonged impact of the 
intervention. When comparing post-intervention scores with year three scores, there were 
statistically significant improvements in the domains of susceptibility (p = 0.014), self-efficacy 
(p = 0.027), and perhaps most impressive were the dramatic gains in confidence (p < 0.001), a 
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domain that was essentially equivalent between pre and post intervention scores.  In spite of the 
improvements to cervical health literacy, up-to-date Pap testing was not significantly different 
(see figure 3) with 74% of participants reporting up-to-date Pap testing at year three compared to 
75% at the pre-intervention phase. Such a finding is curious and warrants further exploration to 
determine the cause.  
 Results from the linear model (table 3) brought to light the predictive value of WHO 
based social determinants when applied to the dependent variable of cervical health literacy. 
Although there were no statistically significant predictors for the domains of knowledge and 
benefits, the other domains all had an independent variable of predictive value. Independent 
variables with a positive linear relationship included food insecurity with the barriers domain (b 
= 0.70, p = 0.006), receiving public benefits with the motivation domain (b = 0.62, p = 0.038), 
and age with the confidence domain (b = 0.03, p = 0.03). However, it is important to note that a 
0.03 gain in confidence score for each year increase is minimal and the standard error of 0.01 
emphasizes the precision of the model for generating a statistically significant result. 
Independent variables that had a negative linear relationship included a past cervical cancer 
diagnosis in the severity domain (b = – 1.15, p = 0.012), having attained a high school education 
or beyond in the susceptibility domain (b = – 0.82, p = 0.006), and having experienced racism in 





Figure 2. Women’s health literacy scores pre-intervention, post-intervention, and at year 3 (n = 
111). 
    
    
    




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The value at the “Year 3” point is the p-value of test for comparing pre-intervention vs. year 3.   






















 In revisiting data from a clinical trial centered on incarcerated women, there were WHO 
defined social determinants of health, specifically related to lower socioeconomic standing, that 
differed between the comparison groups over the long-term.  Further, social determinants of 
health had predictive value for one of the primary outcomes of the original study, cervical health 
literacy.  These findings indicate that even among one of the most vulnerable populations, 
women with criminal justice histories, social determinants are still associated with stratification 
and lead to differential outcomes. This is in line with previous works where social determinants 
stratified and affected health outcomes of another vulnerable population, immigrants (24). In the 
context of clinical trials, the ALLHAT social determinant analysis also had similar findings 
where those pertaining to the lowest income quintile were less likely to adhere to scheduled 
long-term follow-up visits (8).  Such findings signify critical considerations for retention 
strategies in future clinical trials involving incarcerated women. If identified at baseline, 
allocating more resources to participants with the poorest socioeconomic standing may translate 
to greater retention and in turn yield more valid generalizable results.  The ALLHAT trial 
highlights the consequences of failing to account for these factors with a 1:5 participant ratio of 
the lowest to highest income quintiles respectively (8).  Thus, if our society prioritizes equitable 
and evidence-based healthcare, it is imperative to address the social determinants of health when 
designing and implementing clinical trials, especially when the trial involves a vulnerable 
underrepresented population.  
 The present study also generated other notable results that merit further discussion. One 
variable that was statistically significant and contrary to expectations was a history of child 
physical or sexual abuse associated with the long-term follow-up group. The literature is 
extensive on how a history of child abuse translates to worse health outcomes especially in 
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mental health (25).  Nonetheless, there was not a significant difference between the groups in 
terms of a history of mental illness. Taking into account the high prevalence of histories of child 
physical or sexual abuse coupled with a relatively small sample size, this finding may represent a 
sampling error. Another possible explanation for these findings is that women with histories of 
sexual abuse might perceive a greater need for their own sexual empowerment, endearing them 
to an intervention like SHE more so than women who did not experience such abuse. The 
literature supports this notion with findings that incarcerated women’s support from other 
prisoners was integral to their wellbeing (26). For participants retained over the course of the 
three years, the sustained and in some cases improved cervical health literacy domain scores 
were impressive. This points to the profound long-term impact that the 10 hour SHE intervention 
had on our participants. Additionally, the trend that ethnoracial minorities had greater long-term 
retention than white participants may reflect an approach used in the SHE intervention, as both 
the principle investigator and project manager are women of color.  Future clinical trials with 
incarcerated women could evaluate how ethnoracial congruency between participants and study 
coordinators influences long-term retention. All in all, these findings allude to the potential for 
replicating this approach in successfully designing behavioral clinical trials with incarcerated 
women.  
Surprisingly, sustained cervical health literacy scores did not correspond to a higher 
percentage of up-to-date Pap testing in our sample. However, prior to considering potential 
explanations for this finding, it is worth mentioning that the percentage did not appreciably 
decline and was just below the 76.1% national average of up-to-date Pap testing in women aged 
18-44 (27). Although this study applied WHO social determinants to the context of a clinical 
trial, the social determinants of health arose from repeated observations that social positionality, 
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when controlling for other factors, confers differential health outcomes.  Women with criminal 
justice histories generally experience a greater proportion of the social determinants of health 
risk factors and this could account for the discrepancy.  Since Pap testing rates are similar to 
national averages but cervical cancer prevalence is drastically higher among incarcerated 
women, future studies should be conducted to identify the mechanisms accounting for such 
differential outcomes. It is possible that empowering participants with cervical health literacy 
may in and of itself be insufficient to overcome the structural forces that propel worse outcomes 
for incarcerated women 
There are limitations in this study to acknowledge. Overall, the comparative analysis in 
this study identified lower than expected statistically significant differences between groups. One 
reason for this was the limitation in taking a retrospective analytical approach. Such an approach 
was constraining because it did not allow alterations to the design to account for rapid jail 
turnover, a confounding variable that greatly affected the baseline comparison.  Moreover, the 
sample size was fairly small particularly at the stage of the long-term follow-up analysis.  A 
larger sample size would reduce the type II error rate and hence, a larger study may detect a 
greater number of differences using the same approach. A final limitation is that incomplete data 
was used for analysis due to missing observations (i.e., nonresponses on survey items). This 
likely reduced the statistical power of conclusions made in this paper and reduced the true 
representativeness of the sample. However, the data appears to be, at least, missing at random 
and thus minimal bias was introduced to the analysis. 
 Ultimately, there is a crucial need to expand clinical trials involving incarcerated women 
to realize equitable healthcare.  Understanding factors influencing participation, retention, and 
outcomes in clinical trials is a requisite step for greater engagement of this population by the 
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research community.  This study was the first to provide insight on these factors at the level of a 
single clinical trial comprised of incarcerated women. Future investigations can build off of this 
work by accounting for factors identified in this study to further characterize the barriers 
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